Combining short periods of leg compression with medications like heparin can be helpful in significantly decreasing a patient's risk of deep vein thrombosis, according to a team of Cochrane researchers.
The researchers analysed data from 11 trials involving 7,431 patients, and found that a combined approach to prevention reduced the risk of DVT from 4 in 100 to less than 1 in 100 when compared to anticoagulants alone. hen compared to compression alone, the risk of DVT was reduced from 4 in 100 to 1 in 100.
Deep Vein Thrombosis Risk Double in People With Desk-Bound Jobs
And you thought that desk-bound jobs only expanded your waistline. According to a new study, office workers who sit at a desk for eight hours a day and spend more than three hours
Advertisement
"Our results support guidelines that already recommend the combined use of medication and leg compression to prevent deep vein blood clots," says lead researcher, Stavros Kakkos of the Henry Ford Hospital in Detroit, Michigan.
The researchers, however, are still unsure whether the combined approach can decrease a patient's risk of a life-threatening pulmonary embolism, which is caused by a clot travelling to the lungs.
"If these clots get into the lungs they can be fatal. We urgently need more studies to find out whether combined preventative approaches are also useful in preventing pulmonary embolism," says Kakkos.
Source: ANI
RAS/SK
"If these clots get into the lungs they can be fatal. We urgently need more studies to find out whether combined preventative approaches are also useful in preventing pulmonary embolism," says Kakkos.
Source: ANI
RAS/SK
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial